We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

968:HKEXXinyi Solar Holdings Ltd. Analysis

Data as of 2026-06-10 - not real-time

MYR 4.10

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Technical outlook appears bullish with the 20‑day SMA (3.66) above the 50‑day (3.61) and 200‑day (3.53) averages, a bullish MACD histogram, and an RSI perched at the extreme high end of the scale. Price is trading at 4.10 MYR, comfortably above the 20‑day SMA and within a narrow band between a support level of 3.60 MYR and a resistance ceiling of 4.24 MYR. The market is in an extreme greed sentiment environment, as reflected by the fear‑greed index of 83.46.
Fundamental picture is mixed: revenue has contracted sharply (‑49%), though gross and operating margins remain respectable at 33% and 28% respectively. Cash generation is weak, with operating cash flow and free cash flow both negative, and the balance sheet carries a sizable debt load (≈ 420 M MYR) resulting in a debt‑to‑equity ratio above 40. The dividend yield is modest (0.24%) with a very low payout ratio (≈ 3%). Valuation metrics are attractive – the trailing PE of 13.7 is well below the industry average of 33.1, and the price‑to‑book of 2.29 suggests the stock may be undervalued. Low beta (≈ 0.12) indicates limited market‑wide price swings, yet 30‑day volatility is high (≈ 26%) and trading volume is thin, pointing to liquidity concerns.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • RSI at extreme overbought levels
  • Price approaching key resistance
  • Thin trading volume increasing downside risk

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Undervalued relative to peers
  • Weak revenue growth and negative cash flow
  • High debt burden limiting operational flexibility

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Attractive valuation metrics (low PE, reasonable PB)
  • Low market beta suggesting stability over time
  • Potential upside if turnaround in cash generation and debt reduction occurs

Key Metrics & Analysis

Financial Health

Revenue Growth-49.30%
Profit Margin13.17%
P/E Ratio13.7
ROE21.06%
ROA9.02%
Debt/Equity42.04
P/B Ratio2.3
Op. Cash FlowMYR-194755280
Free Cash FlowMYR-106593136
Industry P/E33.1

Technical Analysis

TrendBullish
RSI99.7
SupportMYR 3.60
ResistanceMYR 4.24
MA 20MYR 3.66
MA 50MYR 3.61
MA 200MYR 3.53
MACDBullish
VolumeStable
Fear & Greed Index83.46

Valuation

GradeUndervalued
TypeValue
Dividend Yield0.24%

Risk Assessment

Beta0.12
Volatility25.69%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.